| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/04/2008 | US20080213764 Human Protooncogene and Protein Encoded Therein |
| 09/04/2008 | US20080213763 For diagnosing cancers including leukemia, uterine cancer, lymphoma, colon cancer, lung cancer, and skin cancer |
| 09/04/2008 | US20080213760 Compositions and methods for protein isolation |
| 09/04/2008 | US20080213759 Novel Angiogenesis Inhibitor |
| 09/04/2008 | US20080213430 nucleic acid constructs, vectors, and host cells; detergents; transgenic plants; animal feeds |
| 09/04/2008 | US20080213427 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides |
| 09/04/2008 | US20080213426 Producing food products from a transgenic non-human animal with increased number of ribs; treating obesity, spinal cord injury, kidney, nervous system and muscular diseases; antisense agents |
| 09/04/2008 | US20080213340 Alzheimer's prevention oral vaccines; inserting expression vector into agrobacterium and culturing |
| 09/04/2008 | US20080213315 free of non-300 kD botulinum toxin type A complexes |
| 09/04/2008 | US20080213313 Botulinum toxin treatments |
| 09/04/2008 | US20080213312 Botulinum toxin treatments |
| 09/04/2008 | US20080213311 Neuropeptide Y, kyotorphin, calcitonin-gene related peptides bind receptors; Clostridial toxin HN domain translocates toxin light chain across endosome membrane;Clostridial toxin light chain cleaves a neurosecretory protein; HC domain modified to reduce binding to receptors at neuromuscular junction |
| 09/04/2008 | US20080213310 Use of lytic toxins and toxin conjugates |
| 09/04/2008 | US20080213303 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 09/04/2008 | US20080213297 Method of producing conjugate vaccines |
| 09/04/2008 | US20080213296 Ligand bound viral envelope protein for use in inducing anti-human immunodeficiency virus antibodies; treatment and prevention of viral disease |
| 09/04/2008 | US20080213295 Estrogen receptor polypeptide which induces immune respone; for use in treatment and prevention of cell proliferative disorders; antitumor agents |
| 09/04/2008 | US20080213294 Immunization of dairy cattle with GapC protein against streptococcus infection |
| 09/04/2008 | US20080213292 Soluble And Stabilized Trimeric Form Of Gp41 Polypeptides |
| 09/04/2008 | US20080213291 Malaria vaccines |
| 09/04/2008 | US20080213290 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 09/04/2008 | US20080213287 Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 09/04/2008 | US20080213286 Composition comprising mastermind domain (MAM) polypeptide for use in treatment of cardiovascular and cell proliferative disorders |
| 09/04/2008 | US20080213285 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| 09/04/2008 | US20080213284 Receptor binding polypeptides |
| 09/04/2008 | US20080213272 Vegf-related protein |
| 09/04/2008 | US20080213271 Using dopamine receptor specific immunoglobulin to enhance dopaminergic neurotransmission and treat or prevention nervous system and/or neuropsyciatric disorders |
| 09/04/2008 | US20080213269 Preventive and/or Treating Agent for Cancer |
| 09/04/2008 | US20080213264 Immunogens; vaccines; fusion proteins |
| 09/04/2008 | US20080213262 Inhibition of Islet Amyloid Polypeptide (Iapp) Aggregation for the Treatment of Type 2 Diabetes |
| 09/04/2008 | US20080213255 Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin b peptides |
| 09/04/2008 | US20080213245 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides; gene therapy |
| 09/04/2008 | US20080213240 RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK |
| 09/04/2008 | US20080213234 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 09/04/2008 | US20080213216 Transgenic lymphocytes comprising expression vector coding Fc receptor for use in identifying modulators for prevention and treatment of ifection and immune system disorders |
| 09/04/2008 | US20080213190 Peptide or peptidomimetic compounds containing the Arg-Gly-Asp sequence: new class of diagnostic noninvasive tracers as suitable tools for integrin alpha v beta 3-targeted therapy and imaging; antiproliferation agents; angiogenesis inhibititors; antitumor agents; anticarcinogenic agents; kits |
| 09/04/2008 | US20080213185 Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof |
| 09/04/2008 | US20080213179 Differentially Expressed Nucleic Acids in the Blood-Brain Barrier Under Inflammatory Conditions |
| 09/04/2008 | US20080213174 Radiolabelled Insulin |
| 09/04/2008 | US20080210631 Purified enzyme having an activity in the MTBE degradation path; novel bacterial strain Mycobacterium austroafricanum; bioremediation of water contamination |
| 09/04/2008 | DE102006026591B4 Verfahren zur Isolierung von Kollagen aus kollagenhaltigem Gewebe A method for isolating collagen from collagen-containing tissue |
| 09/04/2008 | CA2679400A1 Combination therapy for treatment of immune disorders |
| 09/04/2008 | CA2679381A1 Engineered anti-il-23r antibodies |
| 09/04/2008 | CA2678603A1 Chloroplast transit peptides for efficient targeting of dmo and uses thereof |
| 09/04/2008 | CA2678404A1 Brachyury polypeptides and methods for use |
| 09/04/2008 | CA2677075A1 Method for activation of helper t cell and composition for use in the method |
| 09/04/2008 | CA2676049A1 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 09/04/2008 | CA2657460A1 Modified clostridial toxins with enhanced translocation capability and enhanced targeting activity |
| 09/03/2008 | EP1964921A2 The high bone mass gene of 11q13.3 |
| 09/03/2008 | EP1964918A1 Protein which can serve as nucleus for polymerization of protein polymer, cell having the polymer introduced therein, and process for production of the cell |
| 09/03/2008 | EP1964854A2 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions |
| 09/03/2008 | EP1964850A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 09/03/2008 | EP1964849A2 Transfection complexes |
| 09/03/2008 | EP1964573A2 Method of inducing and/or enhancing an immune response to tumor antigens |
| 09/03/2008 | EP1964572A2 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 09/03/2008 | EP1963509A1 Catecholamine regulated protein |
| 09/03/2008 | EP1963499A2 Zinc finger binding domains for tnn |
| 09/03/2008 | EP1963486A1 L-amino acid producing bacterium and method of producing l-amino acid |
| 09/03/2008 | EP1963369A2 Il-21 antagonists |
| 09/03/2008 | EP1963365A1 Recombinant gelatin particles for cell adhesion |
| 09/03/2008 | EP1963364A2 Compounds and methods for inhibiting apoptosis |
| 09/03/2008 | EP1963363A2 Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins |
| 09/03/2008 | EP1963362A1 Metastin derivatives and use thereof |
| 09/03/2008 | EP1963361A2 Multimeric complexes of antigens and an adjuvant |
| 09/03/2008 | EP1963360A1 Neuregulin variants and methods of screening and using thereof |
| 09/03/2008 | EP1963359A2 Nucleic acids and methods for producing seeds having a full diploid complement of the maternal genome in the embryo |
| 09/03/2008 | EP1963358A1 Treatment of epstein-barr virus-associated diseases |
| 09/03/2008 | EP1963356A2 Accelerated angiogenesis-inducing protein, compositions inducing accelerated angiogenesis and uses thereof |
| 09/03/2008 | EP1963343A1 Polypeptide protracting tags |
| 09/03/2008 | EP1962961A1 Demibodies: dimerisation-activated therapeutic agents |
| 09/03/2008 | EP1962959A2 Neuropeptide-2 receptor-agonists |
| 09/03/2008 | EP1962886A2 Stable protein formulations |
| 09/03/2008 | EP1962855A2 Trpa1 inhibitors for treating pain |
| 09/03/2008 | EP1962607A2 Defatting collagen |
| 09/03/2008 | EP1962577A2 Transgenic plants with enhanced agronomic traits |
| 09/03/2008 | EP1737478A4 Compositions and methods for controlling insects related to the octopamine receptor |
| 09/03/2008 | EP1730170A4 Method for inhibiting immune complex formation in a subjetc |
| 09/03/2008 | EP1684788B1 Peptide increasing fusiogenic capacity of a gamete |
| 09/03/2008 | EP1622940B1 Analysis and use of par 1 polymorphisms for the risk estimation of cardiovascular diseases |
| 09/03/2008 | EP1587532B1 Survivin-derived peptides and use thereof |
| 09/03/2008 | EP1515614B1 Protein extraction from canola oil seed meal |
| 09/03/2008 | EP1463520B1 Immunisation against chlamydia trachomatis |
| 09/03/2008 | EP1430083B1 T1r taste receptors and genes encoding same |
| 09/03/2008 | EP1426443B1 Human bmcc1 gene |
| 09/03/2008 | EP1407026B1 Process for the preparation of l-threonine using strains of the enterobacteriaceae family which contain enhanced phob and phor genes |
| 09/03/2008 | EP1328289B1 Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof |
| 09/03/2008 | EP1294889B1 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| 09/03/2008 | EP1292613B1 Chimeric GPF-Aequorin as bioluminiscent Ca++ reporters at the single cell level |
| 09/03/2008 | EP1254166B1 Recombinant production of human histone-1 subtypes and use thereof for therapeutic purposes |
| 09/03/2008 | EP1250448B1 High expression and production of high-specific activity recombinant s-adenosyl homocysteinase (sahh) and improved assays for s-adenosylmethionine (sam) |
| 09/03/2008 | EP1192279B1 Diagnostics for fragile plaque disorder |
| 09/03/2008 | EP1180159B1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders |
| 09/03/2008 | EP1161455B1 A novel chimeric protein for prevention and treatment of hiv infection |
| 09/03/2008 | EP1036181B1 The process for expression and production of recombinant protein gp90 derived from glicoprotein envelope of equine infectious anemia virus eiav |
| 09/03/2008 | EP0950098B1 Stable expression of triple helical proteins |
| 09/03/2008 | EP0923940B1 Peptide-based immunotherapeutic agent for allergic diseases |
| 09/03/2008 | EP0906577B1 Screening compounds for the ability to alter the production of amyloid-beta peptide |
| 09/03/2008 | EP0906340B2 Purification of factor viii complex by immunoaffinity chromatography |
| 09/03/2008 | EP0804576B1 A novel haemopoietin receptor |
| 09/03/2008 | EP0789575B1 Peripheral nervous system specific sodium channels, dna encoding therefor, drug screening, and methods of making and using thereof |